Blog
RSS FeedPosted by Michael Wonder on 22 Jun 2017
Turmoil in the individual insurance market — where it came from and how to fix it
21 June 2017 - In recent weeks, some health insurers have announced that they will not offer individual market coverage in ...
Posted by Michael Wonder on 22 Jun 2017
Seattle Genetics submits supplemental biologics license application to FDA for Adcetris (brentuximab vedotin) in cutaneous T cell lymphoma
20 June 2017 - Application based on clinical trial results from the Phase 3 ALCANZA and Phase 2 investigator sponsored ...
Posted by Michael Wonder on 21 Jun 2017
Draft order on drug prices proposes easing regulations
20 June 2017 - In the early days of his administration, President Trump did not hesitate to bash the drug ...
Posted by Michael Wonder on 21 Jun 2017
Senate GOP leaders will present health bill this week, even as divisions flare
20 June 2017 - After weeks of secret deliberations, Senate Republicans are in the final stages of a sweeping rewrite ...
Posted by Michael Wonder on 21 Jun 2017
FDA working to lift barriers to generic drug competition
21 June 2017 - Too many patients are being priced out of the medicines they need. ...
Posted by Michael Wonder on 21 Jun 2017
U.S. FDA approves Mydayis (mixed salts of a single-entity amphetamine product) – a new once daily option for ADHD symptom control in patients 13 years and older
20 June 2017 - Mydayis demonstrated improvements lasting up to 16 hours post-dose, beginning at 2 or 4 hours post-administration, ...
Posted by Michael Wonder on 21 Jun 2017
Neos Therapeutics announces FDA approval of Cotempla XR-ODT (methylphenidate) extended release orally disintegrating tablets for the treatment of ADHD in patients 6 to 17 years old
19 June 2017 - First approved methylphenidate extended release orally disintegrating tablet for the treatment of ADHD. ...
Posted by Michael Wonder on 20 Jun 2017
Democrats protest Senate Republican healthcare secrecy
20 June 2017 - U.S. Democrats took to the Senate floor on Monday to throw a spotlight on behind-the-scenes efforts ...
Posted by Michael Wonder on 20 Jun 2017
FDA to clear path for drugs aimed at cancer causing genes
21 June 2017 - FDA Commissioner Gottlieb talks about push before Senate panel. ...
Posted by Michael Wonder on 20 Jun 2017
So much for Trump going after big pharma
20 June 2017 - President Donald Trump has gone from promising to bring down drug prices to looking like he's been ...
Posted by Michael Wonder on 20 Jun 2017
Trump drug pricing order may be weeks away
20 June 2017 - The White House may wait until after the Senate calls a vote on health reform before issuing ...
Posted by Michael Wonder on 20 Jun 2017
Calls to nix August recess gain steam as GOP agenda hits roadblocks
19 June 2017 - Struggling to make progress on campaign promises like tax and health care reform, rank-and-file congressional Republicans ...
Posted by Michael Wonder on 20 Jun 2017
Melinta Therapeutics announces U.S. FDA approval of Baxdela (delafloxacin) for acute bacterial skin and skin structure infections (ABSSSI)
19 June 2017 - Baxdela offers a new option for treatment of adult patients with acute bacterial skin and skin ...
Posted by Michael Wonder on 20 Jun 2017
Priority generic drug reviews: new FDA draft guidance
19 June 2017 - In preparation of its commitments under the second Generic Drug User Fee Amendments, the US FDA ...
Posted by Michael Wonder on 20 Jun 2017
When cholesterol drugs cost $14,000, an insurance tug-of-war
19 June 2017 - Patients struggle to obtain PCSK9 inhibitors, a powerful class of drugs that lower bad cholesterol in difficult ...